Home › Research › Risk factors
Comparison of personal sound amplification products and conventional hearing aids for patients with hearing loss: A systematic review with meta-analysis
Chen CH, Huang CY, Cheng HL, Lin HH, Chu YC, Chang CY, Lai YH, Wang MC et al.. EClinicalMedicine, 2022-04-07
Topic: Risk, prevention and care in population studies
Plain-language summary
The pooled results showed nonsignificant differences in speech intelligence (SMD, 0.14; 95% CI, -0.19 to 0.47; P = .41; I 2 =65%), sound quality (SMD, -0.37; 95% CI, -0.87 to 0.13; P = .15; I 2 =77%) and listening effort (SMD 0.02; 95% CI, -0.24 to 0.29; P = .86; I 2 =32%). Nonsignificant results were also observed in subsequent analyses after excluding patients with moderately severe hearing loss. Complete sensitivity analyses with all of the possible combinations suggested nonsignificant results in most of the comparisons between PSAPs and conventional hearing aids.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chen, C. H., Huang, C. Y., Cheng, H. L., Lin, H. H., Chu, Y. C., Chang, C. Y., et al. (2022). Comparison of personal sound amplification products and conventional hearing aids for patients with hearing loss: A systematic review with meta-analysis. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101378
Vancouver
Chen CH, Huang CY, Cheng HL, Lin HH, Chu YC, Chang CY, et al. Comparison of personal sound amplification products and conventional hearing aids for patients with hearing loss: A systematic review with meta-analysis. EClinicalMedicine. 2022. doi:10.1016/j.eclinm.2022.101378. PMID: 35434580.
BibTeX
@article{chen2022-35434580,
author = {Chen, C. H. and Huang, C. Y. and Cheng, H. L. and Lin, H. H. and Chu, Y. C. and Chang, C. Y. and Lai, Y. H. and Wang, M. C. and others},
title = {{Comparison of personal sound amplification products and conventional hearing aids for patients with hearing loss: A systematic review with meta-analysis}},
journal = {EClinicalMedicine},
year = {2022},
doi = {10.1016/j.eclinm.2022.101378},
pmid = {35434580},
url = {https://doi.org/10.1016/j.eclinm.2022.101378}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The pooled results showed nonsignificant differences in speech intelligence (SMD, 0.14; 95% CI, -0.19 to 0.47; P = .41; I 2 =65%), sound quality (SMD, -0.37; 95% CI, -0.87 to 0.13; P = .15; I 2 =77%) and listening effort (SMD 0.02; 95% CI, -0.24 to 0.29; P = .86; I 2 =32%).
- Nonsignificant results were also observed in subsequent analyses after excluding patients with moderately severe hearing loss.
- Complete sensitivity analyses with all of the possible combinations suggested nonsignificant results in most of the comparisons between PSAPs and conventional hearing aids.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Study designsystematic review
- Participants124
- Evidence strengthHigh
How this study scored 79/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for effect reported because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 46 of the 58 points we could judge it on, which is 79 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (EClinicalMedicine) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 2 / 4 | 124 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35434580) |
| Free to read | 2 / 2 | Free to read |
| Points | 46 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 46 of the 58 points we could judge it on is 79 out of 100. |
| Total | 79 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “conventional”
2 studies in the library carry the topic tag “conventional”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 2 tagged studies.